When you might want both.

• Forehead lines + flat temples. Botox for the lines, filler for the temple hollow.
• Crow's feet + flat cheeks. Botox for the lines, filler in the upper cheek.
• Jaw slimming + chin projection. Botox in the masseter, filler in the chin.

"They don't compete. They do different things. Most clinics know this, and will still try to sell you both for the wrong reasons."

When neither is the right answer.

• Sagging skin or jowls. You need lifting (Ulthera, Thermage, threads, or surgery), not injectables.
• Dark circles from pigmentation (not hollows). Needs laser or topical treatment, not filler.
• Significant volume loss across the whole face. Fat grafting is more cost-effective long-term than six-plus syringes of filler.

Scenarios where the answer flips.

The decision is rarely the abstract one. Five realistic starting points and the version of the answer that actually applies.

• "I'm 26, never had work done, want a subtle change." Default to neither for one more year. If you still want treatment, a conservative neuromodulator plan is usually easier to reverse in practice than starting with filler. The "tweakment" floor is younger than it should be; resist the salon-grade upsell.
• "I'm 32, my under-eye looks tired even after sleep." If the cause is true hollowing, carefully selected HA filler can help; if the cause is pigment or edema, filler can make the result worse. Botox does nothing here.
• "I'm 40, lines on my forehead that don't go away." Botox first, in low units, and reassess at six weeks. If lines persist at rest, a small amount of HA placed superficially can soften the static groove, but only after the muscle is quieted.
• "I'm 48, my lower face is sliding." Neither product is usually the full answer. This is more often laxity than simple volume loss, so the real comparison may be between energy devices, surgery, and selective filler rather than Botox versus filler alone.
• "I had filler three years ago, my face looks puffier than it should." Persistent or misplaced HA is one possibility. The next step is an in-person assessment with someone willing to consider dissolution before adding more product.

Long-term thinking: 5, 10, and 20 years.

• 5 years of regular Botox. Trained-in restraint. Muscles you stop using atrophy slightly; some patients find they need fewer units to maintain the same effect.
• 5 years of regular filler. Some HA persists longer than the brochures suggest. Imaging studies show residual product at four to five years in some patients. The "lasts six months" figure is the cosmetic effect, not the molecule.
• 10 years of regular Botox. Reduced response can happen in a small minority of patients, including through antibody formation, but it is not the default outcome.
• 10 years of regular filler. Accumulation can become visible in some patients who never paused or dissolved older product. The answer is individualized reassessment, not automatic topping-up.
• 20 years of either. Most patients will have shifted to a maintenance protocol that mixes both with energy devices and, for many, eventual surgical refresh. The plan that starts at 30 is not the plan that ends at 55.

The cost-adjusted decision.

The sticker price hides the math that actually matters: how much you spend over five years to keep the result.

• Botox, three areas, every four months. $900 to $1,500 per year. Five-year total: roughly $5,000 to $7,500.
• Lip filler, 0.5 to 1cc, every nine months. $400 to $700 per visit. Five-year total: roughly $2,700 to $4,500.
• Cheek filler protocol, 2cc, every 18 months. $800 to $1,400 per visit. Five-year total: $2,400 to $4,500.
• Fat grafting, single staged protocol. $6,000 to $10,000 once. Surviving fat permanent; refresh maybe at year 5 to 7. Often cheaper than 5+ years of equivalent filler.

The number that should drive the decision is not "what does this cost today" but "what will my face cost to keep at year five." Filler-maximalists frequently spend more, over a longer period, than they would have on a planned surgical or fat-grafting strategy.

What the marketing won't tell you.

• About Botox. "Brow heaviness" is a real and under-disclosed side effect when forehead muscle is over-quieted without compensation. Treatment requires technique, not just product.
• About filler. Some HA formulations can persist longer than expected and may be found beyond the period patients were originally sold. Lips and tear troughs deserve especially conservative technique.
• About both. The "natural" first visit becomes the baseline against which "more" is later judged. Maintenance dose creep is the most predictable feature of long-term aesthetic medicine.
• About neither. A strong skincare routine, sun protection, sleep, and selected device-based treatments may outperform a year of low-grade injectables for some patients under 40.